MacroH2A1 Immunoexpression in Breast Cancer.
breast cancer
immunohistochemistry
macroH2A1
metastases
prognosis
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
01
2020
accepted:
15
07
2020
entrez:
25
9
2020
pubmed:
26
9
2020
medline:
26
9
2020
Statut:
epublish
Résumé
MacroH2A1 has two splice isoforms, macroH2A1.1 and macroH2A1.2, that have been studied in several form of cancer. In the literature there are not many scientific papers dealing with the role of macroH2A1 in breast cancer. Breast cancer is the most frequent form of malignancy in females. It tend to metastasize to the bone in ~70% of patients. Despite treatment, new bone metastases will still occur in 30-50% of cases with advanced disease. Overall 5-year survival after the diagnosis of bone metastasis is ~20%. Osteoclasts and osteoblasts of the bone microenvironment are engaged by soluble factors released by neoplastic cells, resulting in bone matrix breakdown. This malfunction enhances the proliferation of the cancer cells, creating a vicious cycle. We investigated immunohistochemical expression of macroH2A1 in primitive breast cancer, focusing on the comparison of metastatic and non-metastatic cases. Furthermore, the immunohistochemical expression of macroH2A1 has been evaluated both in all cases of nodal metastases and in distant metastases. Our data demonstrated that macroH2A1 expression was higher expressed in metastatic breast cancer (77%) vs. non-metastatic breast cancer (32%). Also in analyzed metastases cases, a high macroH2A1 expression was detected: 85 and 80% in nodal and distant metastases cases, respectively. These results supported the fact that macroH2A1 is more highly expressed in breast cancer with worst prognosis.
Identifiants
pubmed: 32974186
doi: 10.3389/fonc.2020.01519
pmc: PMC7471871
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1519Informations de copyright
Copyright © 2020 Broggi, Filetti, Ieni, Rapisarda, Ledda, Vitale, Varricchio, Russo, Lombardo, Tuccari, Caltabiano and Loreto.
Références
Cell Rep. 2018 Jul 3;24(1):224-237
pubmed: 29972783
Nature. 1998 Jun 11;393(6685):599-601
pubmed: 9634239
Int J Mol Sci. 2016 Oct 22;17(10):
pubmed: 27782069
Oncologist. 2013;18(12):1298-306
pubmed: 24277771
Nat Genet. 2002 Feb;30(2):167-74
pubmed: 11780141
Science. 1992 Sep 4;257(5075):1398-400
pubmed: 1529340
Oncogene. 2018 Oct;37(43):5749-5765
pubmed: 29925860
Mol Cell Biol. 2006 Jun;26(12):4410-20
pubmed: 16738309
Cancer Cell Int. 2019 Apr 29;19:112
pubmed: 31164793
Genes Dev. 2006 Dec 1;20(23):3324-36
pubmed: 17158748
Mol Cell Biol. 2007 Apr;27(7):2758-64
pubmed: 17242180
J Bone Miner Res. 2017 Mar;32(3):434-439
pubmed: 27606829
Oncogene. 2009 Sep 24;28(38):3423-8
pubmed: 19648962
Histol Histopathol. 2019 Oct;34(10):1141-1150
pubmed: 30973180
Pathol Res Pract. 2016 Nov;212(11):980-987
pubmed: 27546281
Acta Histochem. 2014 Jun;116(5):965-72
pubmed: 24932985
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7635-40
pubmed: 15897469
Genes Dev. 2010 Jan 1;24(1):21-32
pubmed: 20008927
Am J Pathol. 2012 Jun;180(6):2516-26
pubmed: 22542848
Nature. 2010 Dec 23;468(7327):1105-9
pubmed: 21179167
J Biol Chem. 2012 Jun 29;287(27):23171-83
pubmed: 22589551
Epigenomics. 2012 Apr;4(2):221-7
pubmed: 22449192
Nucleic Acids Res. 2014 Jan;42(1):181-92
pubmed: 24071584
Nature. 2015 Jun 4;522(7554):106-110
pubmed: 26017313
Oncogenesis. 2013 Oct 28;2:e77
pubmed: 24165580
Mol Cell Biol. 2011 Oct;31(20):4244-55
pubmed: 21844227
Mol Cell Biol. 2006 Feb;26(3):1156-64
pubmed: 16428466
Nat Struct Mol Biol. 2005 Jul;12(7):624-5
pubmed: 15965484
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62
pubmed: 24114568
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):733-9
pubmed: 21357727
Cancers (Basel). 2018 Feb 27;10(3):
pubmed: 29495465
Nat Struct Mol Biol. 2014 Nov;21(11):981-9
pubmed: 25306110
Nat Rev Cancer. 2011 Jun;11(6):411-25
pubmed: 21593787
Nat Struct Mol Biol. 2009 Oct;16(10):1074-9
pubmed: 19734898
Nat Struct Mol Biol. 2012 Nov;19(11):1139-46
pubmed: 23022728
Oncotarget. 2014 Jun 15;5(11):3428-43
pubmed: 25003966
Nat Rev Mol Cell Biol. 2017 May;18(5):299-314
pubmed: 28144029
Cell Tissue Res. 2015 Oct;362(1):45-60
pubmed: 25948484